◆ 会议时间：2024年5月2日至4日
◆ 会议地点：英国 利兹
◆ 会议简介：
2024年第30届欧洲外科协会(ESA)年会将于2024年5月2日至4日在英国利兹举行。
欧洲外科协会(ESA)成立于1993年，是欧洲最负盛名的外科组织之一。ESA的成员包括欧洲大陆最杰出的外科医生，这些外科医生来自世界领先的学术医疗机构，他们大多是这些机构外科部门的管理者。欧洲外科协会旨在提供一个平台，以介绍普通外科和亚专业外科技术和科学的发展状况宣以及提高医疗/外科专业标准。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)
ESA 2024 - 30th Annual Meeting of the European Surgical Association
Date: 2-4 May 2024
Venue: Queens Hotel, Leeds, United Kingdom
摘要征文投稿：
GENERAL TERMS
> Deadline for Classical Abstracts submission: November 2nd, 2023, 23:59 (CET)
> Deadline for Special Lecture submission : November 30th 2023, midnight (CET)
点此提交摘要>>>Submit Abstract>>>
Prior to the abstract submission some additional information are requested from the Program Committee in order to help the selection process:
- State clearly who is the ESA member Sponsor of the abstract.* 作者资格
- In the abstract section, declare if is a RCT or not.
- Please make sure to choose the surgery specialty to which the abstract belongs.
*We would like to remind you that it is mandatory that the sponsor of the abstract is a member of ESA.Without an ESA sponsor, the abstract will not be considered for evaluation.
Please note the following for the Classical abstracts submission:
Number of Words:
The abstract length is increased to maximum 500 words (title excluded) to allow clearer information in terms of novelty, clinical relevance or translational research, robustness of the statistical analysis and study endpoints.
Title:
According to Annals of Surgery Editorial guidelines.
Background and Aims:
Please provide here what is the established knowledge about the topic of the study, the rationale and the need for the present study and the future clinical implications deriving from conducting the study.
Study Design:
Please provide here the setting of the study, if it is an observational retrospective, propsective or randomized controlled trial or any other type of study design. Please unequivocally define primary and secondary end-points of the study, how the recruitment of patients is accomplished, reasons for eventual exclusion, and the analysis planned to verify the initial hypothesis. These aspects are essential to verify the transparency regarding "what was planned and what was done", in particular, in this section it must clearly specified what specific hypotheses the researchers intended to test and the analytical methods by which they planned to test.
Statistical analysis:
If an RCT, please provide here details about sample size estimation and power of the study. Do not report in this section the sample size of the study population. Provide also specific details about statistical methodologies applied especially when inferential statistic is applied. Statistic must be rigorous and the corresponding author must declare who performed it in the eventual subsequent full submission. Help from a bio-statistician is strongly encouraged. Please include registration number of RCT.
Results:
Please provide here synthetically the results obtained according to the methods used in the study design section. Reviewer will expect to evaluate results that are correctly obtained.
Discussion:
Please be very clear and synthetic. Provide only discussions which are in clear agreement with the results obtained.
Conclusion:
Please explain with few, clear sentences the novelties or innovations contained in the study you are submitting.
Please note the following for the Special lecture abstracts:
Since 2014, one “special article” (up to 500 words) that “aims to address important issues relevant to healthcare or medicine in general and which are of specific interest to the profession of surgery such as quality or safety, surgical reimbursement, surgical education, or other issues facing the profession” is selected by the council (i.e. not by the program committee) and included in the program.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
